FDA permits marketing of mobile medical application for substance abuse disorder

["U.S. Food and Drug Administration" <fda@xxxxxxxxxx>]

If your email program has trouble displaying this email, view it as a web page

	FDA permits marketing of mobile medical application for substance abuse disorder
	Today, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorders (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana and stimulant SUDs. The application is not intended to be used to treat opioid dependence. Continue reading

U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy | www.fda.gov
Manage Preferences | Global Unsubscribe